Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Psoriasis 1Polyps 1Osteoarthritis 1Leukemia, Myeloid, Chronic-Phase 1Hyperplasia 1Colorectal Neoplasms 1Cancer Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Adenomatous Polyposis Coli 1

Interventions

Celecoxib 4Sulindac 2Erlotinib Hydrochloride 2Eflornithine 2Curcumin 2Surveys and Questionnaires 1Suppositories 1Sirolimus 1Sigmoidoscopy 1Gastroscopy 1Endoscopy 1Eicosapentaenoic Acid 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Adenomatous Polyposis Coli × Eicosapentaenoic Acid × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡